Skip to content

The Effect of Electroacupuncture on Obesity

The Effect of Low Frequency Electroacupuncture on Waist Circumference in Obesity-Three Arm Randomized Controlled Trial, Pilot Study

Status
UNKNOWN
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01102075
Enrollment
39
Registered
2010-04-12
Start date
2010-01-31
Completion date
2010-05-31
Last updated
2010-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Keywords

Obesity, Electroacupuncture, Sham electroacupuncture, Waist circumference, Thickness of subcutaneous fat

Brief summary

The purpose of this study is to determine whether electroacupuncture is effective on waist circumference in obesity.

Detailed description

Many studies have reported on the beneficial effects of acupuncture for obesity, although some negative reports also existed.(Wang F. et al. 2008)Recently conducted systematic review of Pittler and Ernst reported that there was insufficient, but not conclusive evidence to support the efficacy of acupuncture and acupressure for weight loss. However, most of these studies had methodological limitation, such as lack of adequate control group or unclear specific effect of electroacupuncture alone because auricular acupuncture was administered as well. In this sudy, we had three-arm randomized controlled trial(with sham control group) to investigate whether electroacupuncture is effective in the treatment of obesity.

Interventions

DEVICEElectroacupuncture

We used Electrical stimulator(STN-111,Stratek)with a frequency of 24 Hz and intensity of 0.27-1.3mA(tolerable strength), asymmetric interactive pulse with continuous stimulation by the pulse generator. The participants were given treatment twice a week for 30 minutes for 5 weeks(10 sessions) by practitioner.(n=13)

DEVICESham electroacupuncture procedure

We used same electroacupuncture device, number and type of needle, duration, frequency of sessions and practitioner as for the EA treatment. Specific details are as described in the arm description.(n=13)

Sponsors

Kyunghee University Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
16 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Waist circumference: Male\>= 90 cm, Female \>= 85 cm * BMI over than 25kg/m2

Exclusion criteria

* Secondary obesity caused by endocrine disease, e.g., polycystic ovary syndrome, diabetes mellitus, Cushing's syndrome, hypothyroidism etc. * Heart disease,e.g.,arrhythmia, heart failure, myocardial infarction, and patient with pacemaker * Hypertension, hyperlipidemia or hypercholesterinemia patients on medication * Stroke or otherwise unable to exercise * Pregnant or lactating women * Childbirth within 6 months * Management for weight control within 3 months * Any other conditions deemed unsuitable for trial as evaluated by the physician-in-charge

Design outcomes

Primary

MeasureTime frame
waist circumferenceAt 5 weeks (post treatment)

Secondary

MeasureTime frameDescription
Waist hip ratioStudy Day 1 (Baseline)
Body Mass IndexStudy Day 1 (Baseline)Body Mass Index was measured by Inbody 720
Body fat ratioStudy Day 1 (Baseline)Body fat ratio was measured by Inbody 720
Visceral Fat AreaStudy Day 1 (Baseline)Visceral Fat Area was measured by Inbody 720
Thickness of abdominal subcutaneous fatStudy Day 1 (Baseline)Thickness of abdominal subcutaneous fat was measured by digital skinfold caliper(FatTrack).
Obesity degreeStudy Day 1 (Baseline)Obesity degree was measured by Inbody 720
Bulimia Test RevisedStudy Day 1 (Baseline)
Korean version of Obesity-related QOL scaleStudy Day 1 (Baseline)
Body Shape QuestionnaireStudy Day 1 (Baseline)
Body weightStudy Day 1 (Baseline)Body weight was measured by Inbody 720

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026